Welcome to Belrose Pharma official website
Contact : 609.917.3013

Belrose

Partnerships

Commercial Partnerships

Belrose relies on its collaborations to advance its development programs to address unmet clinical needs. We

Two of our clinical-stage assets were acquired in 2014 while two of these clinical-stage assets were acquired from publicly-traded Enzon Pharmaceuticals in 2013, as part of Belrose’s acquisition of Enzon’s PEGylation linker technologies.

Belrose leverages its proprietary technologies and proven expertise to provide services and research-stage clinical candidates to development partners.

Belrose currently has development partnerships with several companies interested in leveraging Belrose’s proprietary technology to develop new dosage forms and/or enhance their own pharmaceutical products and/or clinical candidates.

 

Academic & Research Collaborations

In addition to partnerships with private companies, Belrose Pharma has development and collaboration partnerships with the following academic and research institutions:

 

NCI

nci

http://www.nih.gov/about/almanac/organization/NCI.htm

 

Dana Farber

logo

http://www.dfhcc.harvard.edu/